Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interaction Study of ASP8062 and Alcohol in Healthy Volunteers
NCT04003402Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ASP8062 in alcohol use disorder (AUD) (4 arms), sponsored by Astellas Pharma. Primary endpoints: Pharmacokinetics (PK) of ASP8062 in plasma: area under the concentration time curve from the time of dosing extrapolated to time infinity, Pharmacokinetics (PK) of ASP8062 in plasma: maximum concentration and 7 more. Started Jul 2019; status: completed.
02
Drugs
ASP8062
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT04003402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04003402.